Compound tirzepatide vs. Mounjaro: What the science says

What did @chanelica_ actually say?

She documented her first self-injection of compounded tirzepatide after three months on brand-name Mounjaro, walking viewers through her technique: cleaning the vial top with an alcohol wipe, drawing up to the "25 mark" on the syringe, injecting into the right thigh straight from the refrigerator, and reporting zero pain. Her takeaway: "this was absolutely painless" and she already preferred compounded tirzepatide over the brand-name auto-injector pen.

To be clear about what this video is: it is a first-person injection tutorial filmed on a phone, not medical guidance. The creator is transparent about her nerves and experience level. She is not claiming clinical expertise, and that context matters when evaluating what follows.

Does the science back this up?

The injection site choice and basic sterile technique she demonstrates are consistent with published guidance. The pain report is plausible but not universally reproducible, and the refrigerator-to-skin claim deserves scrutiny.

Subcutaneous injection into the anterior thigh is a validated site for GLP-1 receptor agonist administration. The 2022 prescribing information for tirzepatide (Eli Lilly) lists the abdomen, thigh, and upper arm as acceptable sites. Her alcohol-wipe technique, cleaning both the vial septum and the injection site, aligns with standard aseptic practice for vial-drawn injections.

On the cold medication claim: injecting a solution straight from the fridge is generally not recommended. A 2019 review by Usach et al. in the Journal of Diabetes Science and Technology found that cold insulin and subcutaneous biologics can increase injection site discomfort and may affect absorption consistency. Tirzepatide is not insulin, but the principle applies to subcutaneous peptide solutions. Her pain-free experience is possible but should not be taken as the norm.

What did they get wrong (or right)?

The biggest issue is the refrigerator claim. She says "I did this straight out the fridge" as if it were a positive detail. It is not advice anyone should follow as a rule. Several clinical guidelines for subcutaneous injectables recommend allowing the solution to reach room temperature for 15 to 30 minutes before injecting to reduce discomfort and potential absorption variability. She got lucky on pain, but the practice is not best practice.

What she got right: cleaning the vial top before drawing. A lot of first-time self-injectors skip this step. It matters. Contamination of multi-use vials is a real infection risk, and the CDC's injection safety guidelines specifically call out stopper disinfection as a required step. She also demonstrated a slow, controlled injection draw, which reduces the risk of air bubbles in the syringe.

One thing she did not address: air bubble purging. After drawing medication, the standard technique includes tapping the syringe and expelling any air before injecting. It is not visible in her description. For subcutaneous injections this is lower risk than intravenous, but it is still part of proper technique and worth flagging for viewers replicating her process.

What should you actually know?

Compounded tirzepatide is not the same product as Mounjaro or Zepbound. The FDA does not evaluate compounded drugs for safety, efficacy, or manufacturing quality the way it does approved drugs. The creator makes a comparison between the two based on her subjective experience, which she is entitled to share, but viewers should not interpret that as clinical equivalency. The FDA has issued multiple alerts about compounded GLP-1 medications, including a 2024 warning about dosing errors with compounded tirzepatide specifically.

If you are transitioning from a brand-name GLP-1 to a compounded version, that decision should involve your prescribing provider. Dose conversion is not straightforward, and concentration differences between compounded vials and pre-filled brand pens vary by pharmacy. Drawing to a "25 mark" means nothing without knowing the concentration of your specific compounded product, which the creator does not specify.

Self-injection technique is learnable and manageable for most people. But learning it from a TikTok video, even a well-intentioned one, should be a supplement to, not a replacement for, instruction from a pharmacist or clinician.

Bottom line

This video is earnest and mostly harmless, but a few details could lead viewers astray. The refrigerator-to-injection shortcut is the main one to correct. The core technique she shows, site selection, vial cleaning, and slow draw, is reasonable for a first-time self-injector. Just do not treat her pain-free experience as a guarantee, and do not skip letting your medication warm up first.